The Discounted Cash Flow (DCF) valuation of BioLine RX Ltd (BLRX.TA) is 0.40 USD. With the latest stock price at 1.90 USD, the upside of BioLine RX Ltd based on DCF is -78.8%.
Based on the latest price of 1.90 USD and our DCF valuation, BioLine RX Ltd (BLRX.TA) is a sell. selling BLRX.TA stocks now will result in a potential gain of 78.8%.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 14.2% | 10.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 0.28 - 0.93 | 0.40 |
| Upside | -85.0% - -51.2% | -78.8% |